Portfolio (Quarterly)
Guide ↗
RHUMBLINE ADVISERS
· CIK 0001115418| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 3221 | — | SUBARU CORP UNSPONS ADR | — | 30,600.0 | $225K | — | NEW | — | $7.34 | — |
| 3222 | RILY | BRC GROUP HLD INC | Financial Services | 27,895.0 | $224K | — | NEW | — | $8.04 | -11.4% |
| 3223 | GALT | GALECTIN THERAPEUTICS INC | Healthcare | 48,332.0 | $224K | — | NEW | — | $4.64 | -20.7% |
| 3224 | STXS | STEREOTAXIS INC COMMON STOCK USD.001 | Healthcare | 130,042.0 | $224K | — | NEW | — | $1.72 | -17.4% |
| 3225 | ASIC | ATEGRITY SPECIALTY INSUR | Financial Services | 9,300.0 | $224K | — | NEW | — | $24.04 | +7.5% |
| 3226 | ALXO | ALX ONCOLOGY HLDGS INC | Healthcare | 107,902.0 | $223K | — | NEW | — | $2.07 | -1.4% |
| 3227 | — | SHOULDER INNOVATIONS | — | 11,013.0 | $223K | — | NEW | — | $20.28 | — |
| 3228 | — | J. SAINSBURY PLC-SPONS ADR | — | 13,021.0 | $223K | — | NEW | — | $17.13 | — |
| 3229 | RNA | ATRIUM THERAPEUTICS INC | Healthcare | 16,579.0 | $223K | — | NEW | — | $13.45 | -1.9% |
| 3230 | TNXP | TONIX PHARMACEUTICALS HLD | Healthcare | 17,434.0 | $222K | — | NEW | — | $12.76 | -1.6% |
| 3231 | — | ORIENTAL LAND ADR | — | 14,531.0 | $222K | — | NEW | — | $15.28 | — |
| 3232 | DMAC | DIAMEDICA THERAPEUTICS INC | Healthcare | 31,460.0 | $221K | — | NEW | — | $7.04 | -7.4% |
| 3233 | CRD-B | CRAWFORD & CO CL A | — | 19,642.0 | $221K | — | NEW | — | $11.27 | +8.6% |
| 3234 | ENIC | ENEL CHILE SA ADR | Utilities | 49,107.0 | $221K | — | NEW | — | $4.50 | -1.3% |
| 3235 | — | SWIRE PACIFIC LTD SP ADR A | — | 21,030.0 | $220K | — | NEW | — | $10.47 | — |
| 3236 | ALEC | ALECTOR INC | Healthcare | 109,532.0 | $220K | — | NEW | — | $2.01 | +17.4% |
| 3237 | SEG | SEAPORT ENTERTAINMENT GROUP | Real Estate | 8,246.0 | $219K | — | NEW | — | $26.60 | +1.0% |
| 3238 | LRMR | LARIMAR THERAPEUTICS IN | Healthcare | 71,888.0 | $219K | — | NEW | — | $3.05 | +37.1% |
| 3239 | — | Precision Biosciences I | — | 27,864.0 | $219K | — | NEW | — | $7.86 | — |
| 3240 | KOF | COCA COLA FEMSA SAB ADR | Consumer Defensive | 2,060.0 | $219K | — | NEW | — | $106.25 | +5.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
36.9%
Financial Services
11.2%
Industrials
10.3%
Consumer Cyclical
9.9%
Healthcare
9.5%
Communication Services
7.0%
Consumer Defensive
4.5%
Energy
3.4%
Utilities
2.8%
Real Estate
2.7%